Peptide conjugate for oral delivery of hydrophilic peptide analgesics

Details for Australian Patent Application No. 2006275314 (hide)

Owner Metabolic Pharmaceuticals Limited

Inventors Belyea, Christopher Ian

Agent Griffith Hack

Pub. Number AU-B-2006275314

PCT Pub. Number WO2007/014432

Priority 2005904150 02.08.05 AU

Filing date 2 August 2006

Wipo publication date 8 February 2007

Acceptance publication date 29 September 2011

International Classifications

C07K 19/00 (2006.01) Hybrid peptides

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

A61P 25/04 (2006.01) Drugs for disorders of the nervous system

Event Publications

28 February 2008 PCT application entered the National Phase

  PCT publication WO2007/014432 Priority application(s): WO2007/014432

29 September 2011 Application Accepted

  Published as AU-B-2006275314

2 February 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006275315-Polysaccharide synthases

2006275313-Multilayer metallised film